1 - 25 of 94 results for author:"Kemp B.E." in Literature citations
Results Customize
› Repeat search in UniProtKB (47)
| The ancient drug salicylate directly activates AMP-activated protein kinase. Hawley S.A., Fullerton M.D., Ross F.A., Schertzer J.D., Chevtzoff C., Walker K.J., Peggie M.W., Zibrova D., Green K.A., Mustard K.J. et al. Science 336:918-922(2012) · UniProtKB (2) |
| Pro-GRP-derived peptides are expressed in colorectal cancer cells and tumors and are biologically active in vivo. Patel O., Clyde D., Chang M., Nordlund M.S., Steel R., Kemp B.E., Pritchard D.M., Shulkes A., Baldwin G.S. Endocrinology 153:1082-1092(2012) · Mapped (3) |
| Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. Galic S., Fullerton M.D., Schertzer J.D., Sikkema S., Marcinko K., Walkley C.R., Izon D., Honeyman J., Chen Z.P., van Denderen B.J. et al. J. Clin. Invest. 121:4903-4915(2011) · Mapped (3) |
| AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. O'Neill H.M., Maarbjerg S.J., Crane J.D., Jeppesen J., Jorgensen S.B., Schertzer J.D., Shyroka O., Kiens B., van Denderen B.J., Tarnopolsky M.A. et al. Proc. Natl. Acad. Sci. U.S.A. 108:16092-16097(2011) · Mapped (7) |
| AMPK is a direct adenylate charge-regulated protein kinase. Oakhill J.S., Steel R., Chen Z.P., Scott J.W., Ling N., Tam S., Kemp B.E. Science 332:1433-1435(2011) · UniProtKB (3) |
| Ca2+/Calmodulin-dependent protein kinase kinase beta is regulated by multisite phosphorylation. Green M.F., Scott J.W., Steel R., Oakhill J.S., Kemp B.E., Means A.R. J. Biol. Chem. 286:28066-28079(2011) · Mapped (3) |
| Inhibition of Kir2.1 (KCNJ2) by the AMP-activated protein kinase. Alesutan I., Munoz C., Sopjani M., Dermaku-Sopjani M., Michael D., Fraser S., Kemp B.E., Seebohm G., Foller M., Lang F. Biochem. Biophys. Res. Commun. 408:505-510(2011) · Mapped (1) |
| Inhibition of the heterotetrameric K+ channel KCNQ1/KCNE1 by the AMP-activated protein kinase. Alesutan I., Foller M., Sopjani M., Dermaku-Sopjani M., Zelenak C., Frohlich H., Velic A., Fraser S., Kemp B.E., Seebohm G. et al. Mol. Membr. Biol. 28:79-89(2011) · Mapped (7) |
| Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. Steinberg G.R., O'Neill H.M., Dzamko N.L., Galic S., Naim T., Koopman R., Jorgensen S.B., Honeyman J., Hewitt K., Chen Z.P. et al. J. Biol. Chem. 285:37198-37209(2010) · Mapped (4) |
| Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Kalender A., Selvaraj A., Kim S.Y., Gulati P., Brule S., Viollet B., Kemp B.E., Bardeesy N., Dennis P., Schlager J.J. et al. Cell Metab. 11:390-401(2010) · Mapped (3) |
| Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase. Sopjani M., Bhavsar S.K., Fraser S., Kemp B.E., Foller M., Lang F. Mol. Membr. Biol. 27:137-144(2010) · Mapped (5) |
| AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. Dzamko N., van Denderen B.J., Hevener A.L., Jorgensen S.B., Honeyman J., Galic S., Chen Z.P., Watt M.J., Campbell D.J., Steinberg G.R. et al. J. Biol. Chem. 285:115-122(2010) · Mapped (3) |
| Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Beck Jorgensen S., O'Neill H.M., Hewitt K., Kemp B.E., Steinberg G.R. Diabetologia 52:2395-2404(2009) · Mapped (4) |
| Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Jorgensen S.B., Honeyman J., Oakhill J.S., Fazakerley D., Stockli J., Kemp B.E., Steinberg G.R. Am. J. Physiol. Endocrinol. Metab. 297:E57-66(2009) · Mapped (4) |
| Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice. Turpin S.M., Ryall J.G., Southgate R., Darby I., Hevener A.L., Febbraio M.A., Kemp B.E., Lynch G.S., Watt M.J. J. Physiol. (Lond.) 587:1593-1605(2009) · Mapped (4) |
| Low salt concentrations activate AMP-activated protein kinase in mouse macula densa cells. Cook N., Fraser S.A., Katerelos M., Katsis F., Gleich K., Mount P.F., Steinberg G.R., Levidiotis V., Kemp B.E., Power D.A. Am. J. Physiol. Renal Physiol. 296:F801-9(2009) · Mapped (3) |
| Ciliary neurotrophic factor stimulates muscle glucose uptake by a PI3-kinase-dependent pathway that is impaired with obesity. Steinberg G.R., Watt M.J., Ernst M., Birnbaum M.J., Kemp B.E., Jorgensen S.B. Diabetes 58:829-839(2009) · Mapped (8) |
| AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. Dzamko N., Schertzer J.D., Ryall J.G., Steel R., Macaulay S.L., Wee S., Chen Z.P., Michell B.J., Oakhill J.S., Watt M.J. et al. J. Physiol. (Lond.) 586:5819-5831(2008) · Mapped (2) |
| Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. Yeo W.K., Lessard S.J., Chen Z.P., Garnham A.P., Burke L.M., Rivas D.A., Kemp B.E., Hawley J.A. J. Appl. Physiol. 105:1519-1526(2008) · Mapped (5) |
| Hypothalamic CaMKK2 contributes to the regulation of energy balance. Anderson K.A., Ribar T.J., Lin F., Noeldner P.K., Green M.F., Muehlbauer M.J., Witters L.A., Kemp B.E., Means A.R. Cell Metab. 7:377-388(2008) · Mapped (2) |
| AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. McGee S.L., van Denderen B.J., Howlett K.F., Mollica J., Schertzer J.D., Kemp B.E., Hargreaves M. |
| AMP-activated protein kinase subunit interactions: beta1:gamma1 association requires beta1 Thr-263 and Tyr-267. Iseli T.J., Oakhill J.S., Bailey M.F., Wee S., Walter M., van Denderen B.J., Castelli L.A., Katsis F., Witters L.A., Stapleton D. et al. J. Biol. Chem. 283:4799-4807(2008) · Mapped (3) |
| Adipocyte triglyceride lipase expression in human obesity. Steinberg G.R., Kemp B.E., Watt M.J. Am. J. Physiol. Endocrinol. Metab. 293:E958-64(2007) · Mapped (2) |
| Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Fraser S.A., Gimenez I., Cook N., Jennings I., Katerelos M., Katsis F., Levidiotis V., Kemp B.E., Power D.A. |
| Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Steinberg G.R., Michell B.J., van Denderen B.J., Watt M.J., Carey A.L., Fam B.C., Andrikopoulos S., Proietto J., Gorgun C.Z., Carling D. et al. Cell Metab. 4:465-474(2006) · Mapped (13) |